BetterLife Pharma Inc. Stock Canadian Securities Exchange
Equities
BETR
CA08772P2026
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.105 CAD | +5.00% | 0.00% | +75.00% |
Apr. 03 | BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding | CI |
Mar. 04 | BetterLife Pharma Inc. announced that it expects to receive CAD 0.1 million in funding | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 13.32M 18.2M |
---|---|---|---|---|---|
Net income 2022 | -12M -16.4M | Net income 2023 | -9M -12.3M | EV / Sales 2022 | - |
Net Debt 2022 | 139K 190K | Net Debt 2023 | 71.69K 97.97K | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-1.36
x | Employees | 7 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.36% |
1 day | +5.00% | ||
Current month | +16.67% | ||
1 month | -4.55% | ||
3 months | +40.00% | ||
6 months | +61.54% | ||
Current year | +75.00% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 10-12-25 |
Chief Operating Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 20-01-20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 15-02-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 0.105 | +5.00% | 10 290 |
24-04-26 | 0.1 | 0.00% | 3,950 |
24-04-24 | 0.1 | -4.76% | 25,000 |
24-04-23 | 0.105 | 0.00% | 20,000 |
24-04-22 | 0.105 | 0.00% | 16,000 |
Delayed Quote Canadian Securities Exchange, April 29, 2024 at 12:17 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-2.84% | 103B | |
+1.55% | 95.28B | |
+1.46% | 22.15B | |
-16.16% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.18% | 16.05B | |
+5.52% | 13.68B | |
+33.36% | 12.17B |
- Stock Market
- Equities
- BETRF Stock
- BETR Stock